Long-Term Heart Rate Reduction Induced by the Selective I f Current Inhibitor Ivabradine Improves Left Ventricular Function and Intrinsic Myocardial Structure in Congestive Heart Failure
- 6 April 2004
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 109 (13), 1674-1679
- https://doi.org/10.1161/01.cir.0000118464.48959.1c
Abstract
Background— Heart rate reduction (HRR) improves left ventricular (LV) filling, increases myocardial O 2 supply, and reduces myocardial O 2 consumption, which are all beneficial in congestive heart failure (CHF). However, the long-term effects of HRR on cardiac function and remodeling are unknown. Methods and Results— We assessed, in rats with CHF, the effects of long-term HRR induced by the selective I f current inhibitor ivabradine (as food admix for 90 days starting 7 days after coronary artery ligation). To assess intrinsic modifications of LV tissue induced by long-term HRR, all parameters were reassessed 3 days after interruption of treatment. Ivabradine decreased heart rate over the 90-day treatment period (−18% versus untreated at 10 mg · kg −1 · d −1 ), without modifying blood pressure, LV end-diastolic pressure, or dP/dt max/min . Ivabradine significantly reduced LV end-systolic but not end-diastolic diameter, which resulted in preserved cardiac output due to increased stroke volume. In the Langendorff preparation, ivabradine shifted LV systolic but not end-diastolic pressure-volume relations to the left. Ivabradine decreased LV collagen density and increased LV capillary density without modifying LV weight. Three days after interruption of treatment, the effects of ivabradine on LV geometry, shortening, and stroke volume persisted despite normalization of heart rate. Conclusions— In rats with CHF, long-term HRR induced by the selective I f inhibitor ivabradine improves LV function and increases stroke volume, preserving cardiac output despite the HRR. The improvement of cardiac function is related not only to the HRR per se but also to modifications in the extracellular matrix and/or function of myocytes as a consequence of long-term HRR.Keywords
This publication has 10 references indexed in Scilit:
- Tissue Doppler imaging differentiates physiological from pathological pressure-overload left ventricular hypertrophy in rats.Circulation, 2002
- Involvement of the Endothelin System in Experimental Critical Hind Limb IschemiaMolecular Medicine, 2000
- Cytokines and Heart FailureCardiology in Review, 1999
- The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trialThe Lancet, 1999
- Beneficial Effects of Heart Rate Reduction on Cardiac Mechanics and Energetics in Patients With Left Ventricular DysfunctionJapanese Circulation Journal, 1999
- Mode of action of bradycardic agent, S 16257, on ionic currents of rabbit sinoatrial node cellsBritish Journal of Pharmacology, 1996
- Acute and chronic cardiac and regional haemodynamic effects of the novel bradycardic agent, S16257, in conscious ratsBritish Journal of Pharmacology, 1995
- Electrophysiological effects of S 16257, a novel sino‐atrial node modulator, on rabbit and guinea‐pig cardiac preparations: comparison with UL‐FS 49British Journal of Pharmacology, 1994
- Beneficial effects of metoprolol in idiopathic dilated cardiomyopathyThe Lancet, 1993
- Changes in diastolic time with various pharmacologic agents: implication for myocardial perfusion.Circulation, 1979